Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from China Resources Medical Holdings Co ( (HK:1515) ).
China Resources Medical Holdings Co has entered into a new framework agreement for the years 2026 to 2028, known as the CRH PMM Framework Agreement, to replace the expiring agreements by the end of 2025. This agreement involves continuing connected transactions with its controlling shareholder, CRH, and requires approval from independent shareholders due to the significant percentage ratios involved. The company plans to hold an Extraordinary General Meeting (EGM) for this purpose, and Maxa Capital has been appointed as the independent financial adviser to guide the shareholders. The agreement’s approval process and implications are significant for the company’s operations and compliance with Hong Kong’s Listing Rules.
The most recent analyst rating on (HK:1515) stock is a Sell with a HK$3.00 price target. To see the full list of analyst forecasts on China Resources Medical Holdings Co stock, see the HK:1515 Stock Forecast page.
More about China Resources Medical Holdings Co
Average Trading Volume: 6,716,225
Current Market Cap: HK$4.26B
Find detailed analytics on 1515 stock on TipRanks’ Stock Analysis page.